CDC37L1-DT

Across TCGA pan-cancer cohorts, CDC37L1-DT RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated CDC37L1-DT data layer.

The strongest signal is observed in mesothelioma (MESO), where higher CDC37L1-DT RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated CDC37L1-DT expression acts as an unfavorable survival marker, although some lineages such as MESO and OV show a favorable association.

MESO, UCS, and OV are the cancer types where CDC37L1-DT RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Median	All	0.455	0.270	<.001	96	view →
UCS	OS	Median	IV	0.302	0.817	.002	54	view →
OV	OS	Tertile	III,IV	0.899	0.749	<.001	50	view →
SKCM	OS	Tertile	III,IV	0.585	0.296	<.001	36	view →
UVM	DFS	Quartile	III,IV	0.119	0.828	<.001	34	view →
LIHC	OS	Median	II,III,IV	0.737	0.484	.002	29	view →
KIRC	DFS	Tertile	IV	0.401	0.790	.001	27	view →
BLCA	OS	Quartile	II,III,IV	0.711	0.519	.007	20	view →
PAAD	OS	Quartile	All	0.667	0.272	.005	17	view →
COAD	OS	Tertile	All	0.497	0.765	.011	17	view →
THCA	DFS	Median	All	0.976	0.909	.003	17	view →
ACC	OS	Quartile	II,III,IV	0.380	0.889	.007	17	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

CDC37L1-DT–MESO (DFS)

Open the MESO breakdown →